U.S. Markets open in 3 hrs 23 mins

How Novartis’s Alcon Performed in Third Quarter

Mike Benson
How Novartis’s Alcon Performed in Third Quarter

Alcon, the eye care business of Novartis AG (NVS), includes surgical products and vision care products. Alcon reported revenues of ~$1.76 billion during the third quarter of 2018, a 3% increase in year-over-year (or YoY) revenues as compared to ~$1.71 billion in the third quarter of 2017. The growth was driven by a 5% growth in operating revenues, offset by a 2% negative impact of foreign exchange.